Proinflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and IL-17, are thought to play pivotal roles in that joint architecture destruction in RA patients. This evidence concerns the gene IL6 and rheumatoid arthritis.